GO_REF:0000002
Gene Ontology annotation through association of InterPro records with GO terms
GO_REF:0000033
Annotation inferences using phylogenetic trees
GO_REF:0000117
Electronic Gene Ontology annotations created by ARBA machine learning models
GO_REF:0000120
Combined Automated Annotation using Multiple IEA Methods
PMID:1691187
The human alpha 2-macroglobulin receptor: identification of a 420-kD cell surface glycoprotein specific for the activated conformation of alpha 2-macroglobulin.
PMID:6203908
Primary structure of human alpha 2-macroglobulin. V. The complete structure.
PMID:10880251
Involvement of alpha-2-macroglobulin receptor in clearance of interleukin 8-alpha-2-macroglobulin complexes by human alveolar macrophages.
PMID:11435418
Interaction of lecithin:cholesterol acyltransferase (LCAT).alpha 2-macroglobulin complex with low density lipoprotein receptor-related protein (LRP). Evidence for an alpha 2-macroglobulin/LRP receptor-mediated system participating in LCAT clearance.
PMID:12538697
Natural substrates and inhibitors of mannan-binding lectin-associated serine protease-1 and -2: a study on recombinant catalytic fragments.
PMID:14687906
Complex formation between human kallikrein 13 and serum protease inhibitors.
PMID:14718574
The human plasma proteome: a nonredundant list developed by combination of four separate sources.
PMID:15226301
Identification and characterization of the acidic pH binding sites for growth regulatory ligands of low density lipoprotein receptor-related protein-1.
PMID:18485748
Inhibition of ADAMTS-7 and ADAMTS-12 degradation of cartilage oligomeric matrix protein by alpha-2-macroglobulin.
PMID:20458337
MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis.
PMID:21362503
Protein profile of exosomes from trabecular meshwork cells.
PMID:22516433
Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability.
PMID:23399388
The control of the complement lectin pathway activation revisited: both C1-inhibitor and antithrombin are likely physiological inhibitors, while α2-macroglobulin is not.
PMID:23533145
In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.
PMID:25037231
Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver.
PMID:28327460
Comprehensive proteomic characterization of stem cell-derived extracellular matrices.
PMID:28675934
Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics.
PMID:32814053
Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins and Uncovers Widespread Protein Aggregation in Affected Brains.
PMID:33964423
Structural Investigations of Human A2M Identify a Hollow Native Conformation That Underlies Its Distinctive Protease-Trapping Mechanism.
PMID:34139236
Development of selective protease inhibitors via engineering of the bait region of human α(2)-macroglobulin.
PMID:6698368
Mesotrypsin: a new inhibitor-resistant protease from a zymogen in human pancreatic tissue and fluid.
PMID:7679575
Characterization of the antiplasmin activity of human thrombospondin-1 in solution.
PMID:9398211
Human alpha 2-macroglobulin is an osteogenic growth peptide-binding protein.
PMID:9714181
A modified human alpha 2-macroglobulin derivative that binds tumor necrosis factor-alpha and interleukin-1 beta with high affinity in vitro and reverses lipopolysaccharide toxicity in vivo in mice.
Reactome:R-HSA-1454781
MMP1,3,13 (2, 7-12, 19) binding by Alpha-2 macroglubulin
Reactome:R-HSA-158340
kallikrein + alpha2-macroglobulin -> kallikrein:alpha2-macrogloulin
Reactome:R-HSA-481007
Exocytosis of platelet alpha granule contents